More Business Wire
View Older Stories View Newer Stories-
Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate
-
Helmerich & Payne, Inc. Announces Fiscal First Quarter 2025 Conference Call and Webcast
-
KBRA Assigns Preliminary Ratings to Uniti Fiber ABS Issuer LLC and Uniti Fiber TRS Issuer LLC, Series 2025-1 Senior Secured Notes
-
AHF to Meta: Sexual Orientation is not Mental Illness
-
Acuren Corporation Announces Participation in the CJS Securities “New Ideas for the New Year” Virtual Conference
-
KBRA Assigns Preliminary Ratings to OneMain Direct Auto Receivables Trust 2025-1
-
Rocket Lab to Present at Upcoming Conferences
-
Postmedia Reports First Quarter Results
-
DNP Select Income Fund Inc. Section 19(a) Notice
-
Civeo Announces a Six-Year A$1.4 Billion Integrated Services Contract Renewal with Expanded Scope in Australia
-
Kim Rush Named Next President of NW Natural Gas Company
-
Hamilton ETFs Announces Fee Holiday for Hamilton Canadian Bank Equal-Weight Index ETF (TSX Ticker: HEB) & Hamilton Canadian Financials Index ETF (TSX Ticker: HFN)
-
Inovalis Real Estate Investment Trust Announces the Conditional Sale of 87.5% of the Arcueil Property for €37.5 Million
-
Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
-
Dream Unlimited Corp. Provides Asset Management Business Update
-
YES Receives Multiple Orders of VertaCure PLP Systems for Advanced Packaging
-
Mr. Cooper Group Announces Leadership Transition at Xome
-
GrafTech Announces Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast
-
Asbury Automotive Group Schedules Release of Fourth Quarter 2024 Financial Results
-
Granite’s Pat Kelly Elected President of AGC of California for 2025
-
Humana Inc. to Release Fourth Quarter 2024 Results on February 11, 2025
-
Rocket Lab Selected by NASA to Provide Neutron Launch Services Under VADR Launch Contract
-
Lincoln Financial to Report 2024 Fourth Quarter and Full Year Results on February 6
-
Sallie Mae to Release Fourth-Quarter and Full-Year 2024 Financial Results
-
Coeur to Participate in Upcoming TD Securities Global Mining Conference
-
Elastic to Present in Upcoming Investor Conference
-
Cathay General Bancorp to Announce Fourth Quarter and Full Year 2024 Financial Results
-
Best’s Commentary: Insurers Expected to Incur Large Losses From Expanding California Wildfires
-
AM Best Downgrades Credit Ratings for Members of Columbia Lloyds Companies
-
Holly Secures $2.2M to Solve Million-Job Vacancy Crisis in Government Workforce
-
Bankwell Financial Group, Inc. Announces Date of Fourth Quarter Earnings Conference Call
-
Macy's, Inc. Confirms Planned Macy's Store Closures
-
Ryan Specialty to Announce Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025
-
MetLife to Hold Combined Earnings and Outlook Conference Call
-
AvalonBay Communities, Inc. Announces Fourth Quarter 2024 Earnings Release Date
-
Genworth Financial Schedules Earnings Conference Call for February 19
-
Juniper Networks Announces Date of Fourth Quarter and Fiscal Year 2024 Preliminary Financial Results
-
Cloudflare Announces Date of Fourth Quarter 2024 Financial Results
-
Mastercard Incorporated to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results
-
PagerDuty to Present at the 27th Annual Needham Growth Conference
-
Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
-
QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care
-
Atlassian Announces Date for Second Quarter of Fiscal Year 2025 Financial Results
-
Block Announces Ticker Symbol Change to XYZ; To Report Fourth Quarter Results
-
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025
-
JFrog Announces Timing of Fourth Quarter and Fiscal 2024 Financial Results
-
FORE Biotherapeutics Highlights Recent Pipeline Achievements for its Targeted-Oncology Program and Provides Strategic Objectives for 2025
-
Morningstar DBRS Deems Radian Real Estate Management Acceptable Due Diligence Provider
-
SkyWest, Inc. Announces Fourth Quarter and Full Year 2024 Results Call Date
-
Marea Therapeutics Provides Update on Corporate Progress Including Positive Topline Results from Phase 2a Clinical Trial of MAR001 for Cardiovascular Disease and Disclosure of Second Lead Pipeline Pro
